Cardiac PET Perfusion & Myocardial Blood Flow⁸²Rb · ¹³N-ammonia · ¹⁸F-flurpiridaz

Quick Answer

Cardiac PET perfusion offers higher image quality and, uniquely, absolute myocardial blood flow (MBF, mL/g/min) and myocardial flow reserve (MFR = stress MBF ÷ rest MBF). Rb-82 (generator-produced, ~76 s half-life) and N-13-ammonia (cyclotron, ~10 min) are the main tracers; stress is almost always pharmacologic because of the short half-lives. A reduced global MFR flags balanced multivessel disease and coronary microvascular dysfunction that relative imaging can miss.

Definition & Role

Cardiac PET perfusion images regional myocardial tracer uptake at rest and stress like SPECT, but with inherent CT attenuation correction, superior counts, lower radiation, and — critically — the ability to quantify absolute flow. It is used for diagnosis and risk stratification of CAD, particularly in larger patients, when balanced/microvascular disease is suspected, and where SPECT is equivocal.

Physiology — Why Absolute Flow Matters

Relative perfusion compares territories to each other, so when every territory is underperfused (balanced multivessel or left-main disease), none stands out and the scan can look falsely uniform. Absolute MBF and MFR measure flow against an external scale, exposing globally reduced reserve. Low MFR with normal epicardial arteries identifies coronary microvascular dysfunction — an increasingly recognized cause of angina (INOCA/ANOCA).

Tracers

Preparation

Same vasodilator precautions as SPECT: hold caffeine/methylxanthines (~12–24 h) and screen contraindications (high-grade AV block, bronchospastic disease). Weight-based tracer activity; ensure accurate list-mode/dynamic acquisition for flow quantification.

Acquisition

Rest and stress perfusion with dynamic (list-mode) imaging to derive time–activity curves for kinetic flow modeling, plus gated data for function. Because Rb-82 decays in seconds, imaging begins almost immediately after infusion, and PET gating captures peak-stress (not post-stress) function.

Myocardial Blood Flow & Reserve

• MBF is quantified from the dynamic first-pass data using kinetic models (accounting for each tracer's extraction fraction, which falls at very high flows).
• MFR = stress MBF ÷ rest MBF. Normal MFR is generally > 2.0; values < 2.0 associate with worse outcomes, and a markedly reduced global MFR raises concern for balanced multivessel disease or microvascular dysfunction. (Exact thresholds vary by tracer, software, and lab — validate locally.)

Interpretation

Combine relative perfusion (defect location/size/reversibility, summed scores), gated function, and absolute MBF/MFR. A normal relative scan with globally reduced MFR should prompt consideration of diffuse/balanced disease or microvascular dysfunction. Global MFR is prognostic across the perfusion spectrum (Murthy, Circulation 2011): reduced reserve carries higher cardiac-mortality risk even when relative images look normal.

Reporting Checklist

• Report relative perfusion (SSS/SRS/SDS, % myocardium), gated LVEF/volumes, and absolute MBF/MFR (global and regional).
• Flag a normal relative scan with low MFR as possible balanced/microvascular disease.
• State stress agent, caffeine-hold confirmation, and any motion/misregistration limitation.
• Use lab-specific MFR thresholds, not a single universal cutoff.

Common Pitfalls

• Patient motion between CT (transmission) and emission → attenuation-correction misregistration artifacts (classically anterior/lateral).
• Caffeine blunting the vasodilator response → underestimated hyperemic MBF and MFR.
• Applying a single universal MFR cutoff without lab-specific validation.
• Poor list-mode/dynamic acquisition invalidating flow modeling.

Board Pearls

Relative perfusion can look falsely uniform in balanced multivessel disease (all territories underperfused). Absolute MBF and flow reserve (MFR = stress ÷ rest MBF) unmask this by showing a globally reduced reserve, and low MFR also identifies coronary microvascular dysfunction with normal epicardial arteries.

PET gating captures peak-stress function (imaging is near-simultaneous with stress), and PET brings inherent CT attenuation correction plus better images in larger patients. Global MFR is prognostic even when relative images look normal.

Acquire dynamic (list-mode) rest and stress data so a time–activity curve can be fit for kinetic MBF modeling. Tracer trade-offs: Rb-82 (generator, no cyclotron, but larger positron range slightly limits resolution) vs N-13-ammonia (higher, more flow-stable extraction, needs a cyclotron) vs F-18-flurpiridaz (now FDA-approved as Flyrcado; distributable, possibly treadmill-capable). Beware caffeine (blunts hyperemia) and CT–emission misregistration (anterior/lateral artifacts).

Related Pages

• Protocols: MPI SPECT, stress testing, myocardial viability, nuclear cardiology overview.
• Tracers: Rubidium-82, N-13-ammonia.
• Pitfalls: Pearls, pitfalls & normal variants.

Figure / Diagram Suggestions

• A balanced-ischemia schematic: uniform relative perfusion but globally low MFR.
• Tracer comparison panel (generator vs cyclotron, half-life, extraction).
• A flow-modeling curve (dynamic first-pass time–activity fit).

Self-Check (Board-Style)